Welcome to our dedicated page for Earth Science Te SEC filings (Ticker: ETST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Earth Science Tech, Inc. (ETST) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Earth Science Tech is a Florida corporation whose common stock trades on the Over the Counter Bulletin Board under the symbol ETST and is registered under Section 12(g) of the Securities Exchange Act of 1934, as noted in its 8-K reports.
Through these filings, investors can review how Earth Science Tech documents material events and corporate actions tied to its role as a strategic holding company in the healthcare and pharmaceutical sectors. Recent Form 8-K filings describe, among other items, the company’s directive to update its industry classification to SIC 2834 (Pharmaceutical Preparations), its engagement with an investor relations firm, and its qualification for the OTCID tier. Another 8-K details an amendment to the Articles of Incorporation reducing authorized common shares from 350,000,000 to 300,000,000, reflecting share structure decisions approved via shareholder consent and corporate resolutions.
While this page focuses on current and historical SEC submissions, Stock Titan enhances usability with AI-powered summaries that help explain the significance of filings without altering their content. As new documents are posted to EDGAR, such as additional 8-Ks or other periodic reports, they are captured here with real-time updates so users can quickly see changes related to regulatory status, capital structure, and strategic announcements referenced in company press releases.
Investors researching ETST can use this resource to understand how Earth Science Tech reports its pharmaceutical classification, OTC market status, and governance decisions, and to connect those disclosures with its broader operations in compounding pharmacies, telemedicine, real estate development, and consumer brands.
Earth Science Tech, Inc. filed a current report to disclose that it has issued a press release about an industry classification update. On January 6, 2026, the company announced a directive industry classification update to Standard Industrial Classification (SIC) code 2834, which is used for pharmaceutical-related entities. The disclosure notes that the company has formally identified as a pharmaceutical entity since 2022. The press release describing this classification update is included as an exhibit to the report.
Earth Science Tech, Inc. reported that on January 5, 2026 it issued a press release announcing its engagement with Hayden IR. The company furnished this update as an "Other Event" and attached the full press release as Exhibit 99.1 to provide additional detail about the new engagement.
Earth Science Tech, Inc. (ETST) filed an 8-K announcing it issued a press release sharing results for the period ended September 30, 2025. The disclosure is furnished under Item 7.01 (Regulation FD) and is not deemed “filed” for purposes of Section 18, nor incorporated by reference unless expressly stated. Exhibit 99.1 contains the press release, and Exhibit 104 provides the cover page Inline XBRL data. The report was signed by Giorgio R. Saumat, CEO and Chairman.
Earth Science Tech, Inc. (ETST) filed its Q2 FY2026 10‑Q, reporting higher sales and profits. For the quarter ended September 30, 2025, revenue was $9,050,626 with gross profit of $6,723,984 (74% margin). Net income was $945,897, or $0.003 per share. For the six months, revenue reached $17,810,816, gross profit $12,814,758 (71% margin), and net income $1,402,611 ($0.005 per share).
The balance sheet showed total assets of $8,667,416 and stockholders’ equity of $5,075,823. Cash was $1,235,374. Operating cash flow was $1,181,196, offset by investing cash outflows of $940,788 and financing cash outflows of $478,262.
The company continued its buyback program, repurchasing 1,510,000 shares in the quarter for $282,370, and 2,560,296 shares year‑to‑date for $469,428. Subsequent to quarter‑end, 744,603 additional shares were repurchased. ETST completed acquisitions on April 1, 2025 (Las Villas Health and DOConsultations for $200,000; 80% of Magnefuse for $240,500), and recorded related goodwill. As of October 29, 2025, common shares outstanding were 292,407,607 and preferred shares were 1,000,000.
Earth Science Tech (ETST) amended its Articles of Incorporation to reduce its authorized common stock, lowering the limit from 350,000,000 to 300,000,000 shares. The change was approved by majority shareholder written consent and a corporate resolution on August 19, 2025, and the State of Florida stamped and uploaded the amendment on October 10, 2025.
FAQ
What is the current stock price of Earth Science Te (ETST)?
What is the market cap of Earth Science Te (ETST)?
